Cargando…

Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 Study

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS) improves overall survival (OS). We evaluated the impact of MDS genetics on the benefit of HCT in a biological assignment (donor v no donor) study. METHODS: We performed targeted sequencing in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Versluis, Jurjen, Saber, Wael, Tsai, Harrison K., Gibson, Christopher J., Dillon, Laura W., Mishra, Asmita, McGuirk, Joseph, Maziarz, Richard T., Westervelt, Peter, Hegde, Pranay, Mukherjee, Devdeep, Martens, Michael J., Logan, Brent, Horowitz, Mary, Hourigan, Christopher S., Nakamura, Ryotaro, Cutler, Corey, Lindsley, R. Coleman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552956/ https://www.ncbi.nlm.nih.gov/pubmed/37607457 http://dx.doi.org/10.1200/JCO.23.00866

Ejemplares similares

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
por: Nakamura, Ryotaro, et al.
Publicado: (2021)

Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome
por: Dillon, Laura W., et al.
Publicado: (2021)

Prognostic landscape of mitochondrial genome in myelodysplastic syndrome after stem-cell transplantation
por: Dong, Jing, et al.
Publicado: (2023)

Leptotrichia trevisanii Sepsis after Bone Marrow Transplantation
por: Schrimsher, Jennifer M., et al.
Publicado: (2013)

Allogeneic stem cell transplantation and minimal residual disease in patients with AML in first complete remission
por: Versluis, Jurjen, et al.
Publicado: (2018)

1102. Evaluation of Vancomycin Accumulation in Patients with Obesity
por: Assadoon, Maha, et al.
Publicado: (2021)

Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia
por: Gui, Gege, et al.
Publicado: (2023)

Genetics of Myelodysplastic Syndromes
por: Saygin, Caner, et al.
Publicado: (2021)

Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study
por: Zhang, Tao, et al.
Publicado: (2023)

Genetic basis of myelodysplastic syndromes
por: OGAWA, Seishi
Publicado: (2020)

Myelodysplastic syndrome with genetic predisposition
por: Park, Meerim
Publicado: (2021)

OA11.02. A model of integrative care for low back pain
por: Eisenberg, D, et al.
Publicado: (2012)

1102. Ertapenem vs. Nonertapenem Antibiotics in Colorectal Surgery: A Stewardship Opportunity
por: LaDow, Tiffany, et al.
Publicado: (2019)

Matrix transfer techniques for direct paste composite resins
por: Bailey, Oliver, et al.
Publicado: (2022)

Radical cities : across Latin America in search of a new architecture
por: McGuirk, Justin
Publicado: (2014)

Ciudades radicales : un viaje a la nueva arquitectura latinoamericana /
por: McGuirk, Justin
Publicado: (2015)

Radical cities : across Latin America in search of a new architecture /
por: McGuirk, Justin
Publicado: (2015)

Performing social media analytics with Brandwatch for Classrooms: a platform review
por: McGuirk, Mike
Publicado: (2021)

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
por: Hill, Joshua A., et al.
Publicado: (2023)

Impact of Epigenomic Hypermethylation at TP53 on Allogeneic Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndromes
por: Wang, Wei, et al.
Publicado: (2021)

Role and Timing of Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
por: Field, Teresa, et al.
Publicado: (2010)

Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
por: Chen, Yi-Bin, et al.
Publicado: (2009)

The Genetics of Myelodysplastic Syndromes: Clinical Relevance
por: Chiereghin, Chiara, et al.
Publicado: (2021)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
por: Palomo, Laura, et al.
Publicado: (2021)

Seco-tremulane Sesquiterpenoids from the Cultures of the Medicinal Fungus Irpex lacteus HFG1102
por: Chen, He-Ping, et al.
Publicado: (2018)

The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking
por: Khoo, Shaun Yon-Seng, et al.
Publicado: (2017)

Irlactane and Tremulane Sesquiterpenes from the Cultures of the Medicinal Fungus Irpex lacteus HFG1102
por: Chen, He-Ping, et al.
Publicado: (2020)

Fit Older Adults with Advanced Myelodysplastic Syndromes: Who is Most Likely to Benefit from Transplant?
por: Abel, Gregory A., et al.
Publicado: (2020)

IFNL4 and donor selection for matched unrelated donor haematopoietic stem-cell transplantation
por: Westervelt, Peter
Publicado: (2020)

Disease Management of Dairy Calves and Heifers
por: McGuirk, Sheila M.
Publicado: (2008)

Malignant Post-Transplant Lymphoproliferative Disorder of Nasopharynx in Myelodysplastic Disorder
por: Luan, Chih-Wei, et al.
Publicado: (2021)

How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms
por: Gurnari, Carmelo, et al.
Publicado: (2022)

Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism
por: Pawar, Rahul, et al.
Publicado: (2014)

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
por: Alessandrino, Emilio Paolo, et al.
Publicado: (2013)

Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo
por: Wang, Xiao, et al.
Publicado: (2018)

1102. Pediatric Hepatitis C Screening by Maternal Hepatitis C Viral Load Status in Pregnancy
por: DiNicola, Julia, et al.
Publicado: (2023)

Genetic barriers in transplantation medicine
por: Edinur, Hisham A, et al.
Publicado: (2016)

Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation
por: McGuirk, Joseph, et al.
Publicado: (2009)

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
por: Kontandreopoulou, Christina-Nefeli, et al.
Publicado: (2022)

Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation
por: Gagelmann, Nico, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f9vuh6sr6uijqnb80q1efpa3nm